There were 209 patients included in the study; 103 received the ProDisc and 106 underwent ACDF. The seven-year follow-up rate was 92 percent — 152 of 165 patients. Here are five key findings.
1. The procedures were both effective introducing neck and arm pain as well as improving and maintaining function and health-related quality of life.
2. Around 88 percent of the ProDisc-C patients maintained or improved neurologic status; 89 percent of the ACDF patients reported the same.
3. At the seven-year mark, patients reported 30 secondary surgical procedures performed in 106 of the patients in the ACDF group and seven of the 103 patients in the ProDisc-C group.
4. There weren’t significant differences in device-related adverse events between the groups.
5. The researchers concluded ProDisc-C patients had lower risk for additional surgeries, “suggesting that total disc arthroplasty provides durable results and has the potential to slow the rate of adjacent-level disease,” concluded the study authors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.